Rheumatoid arthritis treated with 6-months of first-line biologic or biosimilar therapy: an updated systematic review and network meta-analysis.

Simpson, E.L. orcid.org/0000-0001-7353-5979, Ren, S. orcid.org/0000-0003-3568-7124, Hock, E.S. orcid.org/0000-0002-8617-8875 et al. (8 more authors) (2019) Rheumatoid arthritis treated with 6-months of first-line biologic or biosimilar therapy: an updated systematic review and network meta-analysis. International Journal of Technology Assessment in Health Care. ISSN 0266-4623

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2019 Cambridge University Press. This is an author produced version of a paper subsequently published in International Journal of Technology Assessment in Health Care. Article available under the terms of the CC-BY-NC-ND license (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: Biological agents; Biosimilar; Network meta-analysis; Rheumatoid arthritis; Systematic review
Dates:
  • Accepted: 14 November 2018
  • Published (online): 6 February 2019
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > Sheffield Centre for Health and Related Research
Depositing User: Symplectic Sheffield
Date Deposited: 11 Feb 2019 11:47
Last Modified: 29 May 2020 10:25
Published Version: https://doi.org/10.1017/S0266462318003628
Status: Published online
Publisher: Cambridge University Press
Refereed: Yes
Identification Number: https://doi.org/10.1017/S0266462318003628
Related URLs:

Download

Share / Export

Statistics